Medical Patent News

RSS

Cybex International defends intellectual property rights related to patented Plate Loaded Leg Press

Cybex International, Inc., a leading manufacturer of premium exercise equipment, announced today that it has decisively responded to infringements of its intellectual property rights related to its patented Plate Loaded Leg Press and the company's pending patent applications for the Bravo Functional Trainer.

22 Apr 2010

Court finds Novamont patents to be valid

The Court found two Novamont patents to be fully valid and a third patent to be partially invalid while also finding that Novamont had not provided proof of the infringement. Not entering into the merit of the case, the Court noted that the analyses on samples of the products of the summoned companies had not been conducted in a two-party process.

21 Apr 2010

USPTO to issue patent for TruFUSE procedure

minSURG International, Inc. is pleased to announce that the United States Patent and Trademark Office will issue on May 4th, 2010 U.S. Patent No. 7,708,761, entitled "Spinal Plug for a Minimally Invasive Facet Joint Fusion System," which provides the Company patent protection for the TruFUSE procedure.

21 Apr 2010

USPTO issues patent covering method of metastatic breast cancer treatment using Bionovo's Bezielle

Bionovo, Inc. announced today that the US Patent and Trademark Office (USPTO) has issued a patent covering a method of using Bionovo's proprietary drug candidate Bezielle® (BZL101) for the treatment of metastatic breast cancer. The patent issued today is Bionovo's second issued patent, with over 70 other patent applications currently pending.

21 Apr 2010

CorMedix receives patent for Neutrolin

CorMedix Inc., a pharmaceutical company focused on developing and commercializing therapeutic products for the treatment of cardiorenal disease, today announced that the U.S. Patent and Trademark Office has issued a patent for the use of Neutrolin for preventing infection and clotting in hemodialysis catheters.

21 Apr 2010

Striking down breast cancer related gene patent may not impact industry, says New York attorney

The recent decision in a Federal District Court in New York to strike down a patent for the breast cancer related BRCA-1 gene may not have the broad impact on the technology industry it had originally been feared to, says a New York attorney.

20 Apr 2010

Epix Pharmaceuticals' MRI imaging intellectual properties to be auctioned on May 28, 2010

Joseph F. Finn, Jr., C.P.A., Assignee for the Benefit of Creditors of Epix Pharmaceuticals, Inc., announced today that the MRI imaging intellectual properties will be auctioned on May 28, 2010. The assets of Epix were transferred to him on July 20, 2009 and he is liquidating them for the benefit of Epix creditors. He recently reached an agreement with Bayer Schering Pharma that permits the sale of the MRI imaging programs.

19 Apr 2010

Enigma Diagnostics receives patent for amplification consumables

Enigma Diagnostics Limited, the decentralised and point-of-care molecular diagnostics company, announced today that the U.S. Patent and Trademark Office has granted U.S. Patent No. 7,659,096 with claims that cover the use of amplification consumables in several current real-time and end point PCR instruments.

19 Apr 2010

U.S. Patent Office issues Notices of Allowance covering PLC Systems's RenalGuard technology

PLC Systems Inc., a company focused on innovative cardiac and vascular medical device-based technologies, today reported that the U.S. Patent and Trademark Office had issued Notices of Allowance for two of PLC's patent applications associated with its RenalGuard® technology.

16 Apr 2010

Researchers say exclusive licensing on genes could hurt patients

The Wall Street Journal reports that Duke University researchers have found in a study published Wednesday that granting "exclusive licenses on individual genes" could hurt patients' chances of pinpointing their risks to develop disease.

16 Apr 2010

Sunlight Research's Stem Cell Industry Report analyzes U.S. Stem Cell patent landscape

Sunlight Research – The Source for Patent Analysis, today announced the release of its comprehensive Stem Cell Industry Report analyzing the U.S. Stem Cell patent landscape. Stem cells are particularly attractive for use as cellular therapies because they self-renew and have the capacity to produce many different specialized cell types.

16 Apr 2010

European patent for XenoPort's investigational compound is valid

XenoPort, Inc. announced today that the European Patent Office (EPO) Opposition Division ruled that the European patent for the composition of matter of XP13512 (European Patent No. 1 404 324) is valid.

16 Apr 2010

Exclusive licensing practices slows innovation in gene testing market

Exclusive licenses to gene patents, most of which are held by academic institutions and based on taxpayer-funded research, do more to block competition in the gene testing market than to spur the development of new technologies for gauging disease risk, say researchers at the Duke Institute for Genome Sciences & Policy (IGSP).

15 Apr 2010

OrbusNeich Medical awarded US patent for "Stent with Helical Elements"

OrbusNeich Medical, Inc., a designer, developer, manufacturer and marketer of innovative medical devices for the treatment of cardiovascular diseases, today announced that on March 23, 2010, the Company was granted U.S. Patent No. 7,682,384 B2, entitled "Stent with Helical Elements." The patent relates to an expandable stent comprised of a plurality of helical segments. The Company noted that it has identified unlicensed use by Boston Scientific Corporation of certain technologies protected under U.S. Patent No. 7,682,384 B2.

15 Apr 2010

POZEN enters Settlement Agreement with Teva over generic Treximet ANDA patent infringement litigation

POZEN Inc., today announced that it has entered into a Settlement Agreement with Teva Pharmaceuticals USA, Inc. (Teva) to resolve a U.S. patent infringement suit related to Teva's filing of an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) to market a generic version of Treximet® (sumatriptan/naproxen sodium) marketed by POZEN's exclusive U.S. licensee, GlaxoSmithKline.

15 Apr 2010

CAS Medical Systems granted Japanese patent for LASER-SIGHT technology in FORE-SIGHT Oximeter

CAS Medical Systems, Inc. today announced that that the Japanese Patent Office has granted a new patent for the Company's LASER-SIGHT® technology used in the FORE-SIGHT® Oximeter.

13 Apr 2010

XOMA expands anti-inflammatory antibody intellectual property portfolio

XOMA Ltd., a leader in the discovery and development of therapeutic antibodies, announced that the U.S. Patent and Trademark Office has issued two new patents that significantly expand the company's intellectual property portfolio relating to its anti-inflammatory antibody, XOMA 052, that targets interleukin-1 beta (IL-1 beta).

13 Apr 2010

Article One Partners concludes AUTO Patent Studies

Article One Partners, the world's largest patent validation firm, today announced the conclusion of two Patent Studies conducted on behalf of a top global automaker, for which $30,000 has been awarded to two Advisors.

13 Apr 2010

Bio-Bridge Science granted Japanese patent covering use of papilloma pseudovirus

Bio-Bridge Science, Inc., a biotechnology company engaged in the commercial development of vaccines and vaccine-related products announced today that the Japanese Patent Office has granted claims in a patent application, and issued a Patent Number 4472724, regarding the use of the papilloma pseudovirus.

13 Apr 2010

Epix Pharmaceuticals' MRI imaging intellectual properties to be auctioned on May 28, 2010

Joseph F. Finn, Jr., C.P.A., Assignee for the Benefit of Creditors of Epix Pharmaceuticals, Inc. ("Epix"), announced today that the MRI imaging intellectual properties will be auctioned on May 28, 2010. The assets of Epix were transferred to him on July 20, 2009 and he is liquidating them for the benefit of Epix creditors. He recently reached an agreement with Bayer Schering Pharma that permits the sale of the MRI imaging programs.

12 Apr 2010

Medical Patent News

Cybex International defends intellectual property rights related to patented Plate Loaded Leg Press

Court finds Novamont patents to be valid

USPTO to issue patent for TruFUSE procedure

USPTO issues patent covering method of metastatic breast cancer treatment using Bionovo's Bezielle

CorMedix receives patent for Neutrolin

Striking down breast cancer related gene patent may not impact industry, says New York attorney

Epix Pharmaceuticals' MRI imaging intellectual properties to be auctioned on May 28, 2010

Enigma Diagnostics receives patent for amplification consumables

U.S. Patent Office issues Notices of Allowance covering PLC Systems's RenalGuard technology

Researchers say exclusive licensing on genes could hurt patients

Sunlight Research's Stem Cell Industry Report analyzes U.S. Stem Cell patent landscape

European patent for XenoPort's investigational compound is valid

Exclusive licensing practices slows innovation in gene testing market

OrbusNeich Medical awarded US patent for "Stent with Helical Elements"

POZEN enters Settlement Agreement with Teva over generic Treximet ANDA patent infringement litigation

CAS Medical Systems granted Japanese patent for LASER-SIGHT technology in FORE-SIGHT Oximeter

XOMA expands anti-inflammatory antibody intellectual property portfolio

Article One Partners concludes AUTO Patent Studies

Bio-Bridge Science granted Japanese patent covering use of papilloma pseudovirus

Epix Pharmaceuticals' MRI imaging intellectual properties to be auctioned on May 28, 2010

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News